Sartorius sets up international scholarship programme
Sartorius sets up international scholarship programme
Sartorius AG has set up a new international scholarship program, "Sartorius International Biosciences Scholarship." It offers final year students and those who have already earned a degree in the natural sciences and/or technology and who would like to gain experience working at a German technology group. In particular, the program addresses scientific junior employees from the global growth regions, such as Asia, Eastern Europe and Latin America. Integrated into global teams, the scholarship program participants will work on selected projects in R&D as well as product marketing in the Biotechnology Division.
Within the scope of the scholarship program, Sartorius will be initially offering ten positions. Already, the company trains around 30 interns at its German locations, in addition to offering multiyear vocational training programs to approximately 90 young employees.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
